Open main menu - A Hematology Oncology Wiki β

Talk:Acute myeloid leukemia, IDH-mutated

Updated ivosidenib ref (full article published). Added enasidenib for 1st line nonfit (no FDA approval, but widely used). Both drugs often used in combination with aza/decitabine, add ena+aza nonfit based on DiNardo et al ASH 2019 abstr 643? --Kporkka (talk) 23:07, 8 January 2020 (EST)

Return to "Acute myeloid leukemia, IDH-mutated" page.